Back to PRLD
MARSHALL WACE, LLP PRLD Position History
Prelude Therapeutics Incorporated • Healthcare
Quarters held
14
Latest value
$539K
Q3 2026
Peak value
$933K
First seen
Q3 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2024 | $224K |
| Q3 2024 | $520K |
| Q4 2024 | $135K |
| Q4 2024 | $363K |
| Q2 2025 | $10K |
| Q2 2025 | $24K |
| Q4 2025 | $5K |
| Q4 2025 | $789K |
| Q1 2026 | $641K |
| Q1 2026 | $586K |
| Q2 2026 | $84K |
| Q2 2026 | $933K |
| Q3 2026 | $19K |
| Q3 2026 | $539K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $539K | 137.8K | — | — |
| Q3 2026 | $19K | 5.0K | — | — |
| Q2 2026 | $933K | 175.0K | — | — |
| Q2 2026 | $84K | 15.7K | — | — |
| Q1 2026 | $586K | 171.5K | — | — |
| Q1 2026 | $641K | 187.4K | — | — |
| Q4 2025 | $789K | 272.0K | — | — |
| Q4 2025 | $5K | 1.9K | — | — |
| Q2 2025 | $24K | 30.0K | — | — |
| Q2 2025 | $10K | 11.7K | — | — |
| Q4 2024 | $363K | 285.8K | — | — |
| Q4 2024 | $135K | 106.4K | — | — |
| Q3 2024 | $520K | 251.1K | — | — |
| Q3 2024 | $224K | 108.0K | — | — |
Other funds holding PRLD
$73.2M
$53.7M
$39.6M
$37.3M
$34.6M
$31.6M